Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)
Close on Nov 17, 2026Market cap $37.82MP/E –Yield –
Elutia operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Elutia's operating cash flow for the twelve months ending Jun 30, 2026 was -$43.99M. For fiscal 2025 it was -$44.81M. The highest annual figure on record is -$7.23M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$44.81M | – |
| FY2024 | Dec 31, 2024 | -$22.66M | – |
| FY2023 | Dec 31, 2023 | -$21.76M | – |
| FY2022 | Dec 31, 2022 | -$21.43M | – |
| FY2021 | Dec 31, 2021 | -$15.45M | – |
| FY2020 | Dec 31, 2020 | -$13.63M | – |
| FY2019 | Dec 31, 2019 | -$7.23M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.46M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.83M | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.43M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.12M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.17M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.39M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.10M | – |
| Q2 FY2021 | Jun 30, 2021 | -$787.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.37M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.04M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.57M | – |
See a number that looks wrong?